Insufficient support for retinoic acid receptor control of synaptic plasticity through a non-genomic mechanism

Front Neuroendocrinol. 2023 Aug 28:101099. doi: 10.1016/j.yfrne.2023.101099. Online ahead of print.ABSTRACTIt is well established that retinoic acid receptors (RARs) function as nuclear receptors that control gene expression in response to binding of the ligand retinoic acid (RA). However, some studies have proposed that RAR-alpha (RARa) controls synaptic plasticity via non-genomic effects outside the nucleus, i.e. effects on mRNA translation of GluA1, a sub-unit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. In order to support this non-genomic mechanism, studies have reported RARa knockout mice or treatment with pharmacological levels of RA and RAR antagonists to propose that RARa is required to control normal synaptic plasticity. A major shortcoming of the non-genomic hypothesis is that there have been no mutational studies showing that RARa can bind the GluA1 mRNA to control GLUA1 protein levels in a non-genomic manner. Also, without a genetic study that removes endogenous ligand RA, it is impossible to conclude that RARa and its ligand RA control synaptic plasticity through a non-genomic signaling mechanism.PMID:37647946 | DOI:10.1016/j.yfrne.2023.101099
Source: Frontiers in Neuroendocrinology - Category: Endocrinology Authors: Source Type: research